Form 8-K - Current report:
SEC Accession No. 0001558370-19-010064
Filing Date
2019-11-06
Accepted
2019-11-06 06:40:42
Documents
14
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vygr-20190707x8kca4c0bc.htm   iXBRL 8-K 43560
2 EX-99.1 ex-99d1.htm EX-99.1 148344
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 1226822
  Complete submission text file 0001558370-19-010064.txt   2011992

Data Files

Seq Description Document Type Size
4 EX-101.SCH vygr-20190707.xsd EX-101.SCH 3297
5 EX-101.LAB vygr-20190707_lab.xml EX-101.LAB 16159
6 EX-101.PRE vygr-20190707_pre.xml EX-101.PRE 10961
14 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20190707x8kca4c0bc_htm.xml XML 4851
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 191195006
SIC: 2836 Biological Products, (No Diagnostic Substances)